Selçuk Cin

Dr. Selçuk Cin


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
MCMerve Cin
Merve Cin
AİAyşenur Akyıldız İğdem
Ayşenur Akyıldız İğdem
SBSibel Bektaş
Sibel Bektaş
ÖGÖzgecan Gündoğar
Özgecan Gündoğar
SCSelçuk Cin
Selçuk Cin
BÇBuğra Çetin
Buğra Çetin
Background/Objectives: Bladder cancer, predominantly urothelial carcinoma, is an important malignancy of the urinary system. Despite the same histologic grade and stage, some patients seem to have a worse prognosis. In this context, the epithelial–mesenchymal transition (EMT), characterized by the loss of E-cadherin and gain of vimentin expression, is an important process in tumor progression. Galectin-3, a lactose-binding protein involved in various cellular processes, has been associated with increased tumor cell migration, invasion, and treatment resistance. Methods: In this study, 223 bladder cancer cases were examined, and E-cadherin, vimentin, and galectin-3 expression was evaluated by immunohistochemical staining in tumor budding areas and invasive components. These markers were also correlated with clinicopathological parameters, including tumor grade and stage. Results: The results indicated a significant decrease in E-cadherin expression and an increase in vimentin staining in higher-grade and higher-stage tumors, supporting EMT involvement. Galectin-3 expression was notably higher in T1 high-grade tumors but decreased in T2 stage tumors. Despite this, no significant correlation was found between galectin-3 and E-cadherin or vimentin, suggesting a complex role of galectin-3 in EMT. Conclusions: High galectin-3 expression in T1 high-grade tumors highlights its potential role in early tumor progression and as a therapeutic target. However, the decrease in its expression in advanced stages underscores the need for further research to understand its multifaceted involvement in bladder cancer. These findings suggest that while galectin-3 may contribute to the EMT and early tumor progression, its exact role and potential as a therapeutic target require more detailed investigation.

24 March 2026 in European Journal of Breast Health
Verified
Journal Article
Open access
PDF file
Merve TokoçinMerve Tokoçin
Merve Tokoçin
TPTuran Pehlivan
Turan Pehlivan
SCSelçuk Cin
Selçuk Cin
BTBülent Toksöz
Bülent Toksöz
OTOnur Tokoçin
Onur Tokoçin
AÇAtilla Çelik
Atilla Çelik
Evaluating the Role of Artificial Intelligence in Enhancing Multidisciplinary Team Decisions for Breast Cancer Management - European Journal of Breast Health

27 August 2018 in Turkish Journal of Surgery
Verified
Journal Article
Open access
OAOzan Akinci
Ozan Akinci
FKFadime Kutluk
Fadime Kutluk
SCSelçuk Cin
Selçuk Cin
SESuphan Erturk
Suphan Erturk
SYSerdar Yuceyar
Serdar Yuceyar
APAsiye Perek
Asiye Perek
Heterotopic ossification is the formation of bone tissues in areas other than the skeletal system. It is more often seen as a complication of orthopedic surgery; however, it is a pathological condition that might be observed during the healing of abdominal incisions in the midline. The aim of this study is to present a case of a 63-year-old male patient with complaints of induration and pain on the region of his previous incision through which he had been operated for achalasia. Heterotopic ossification has also been discussed in the light of the current literature.

29 June 2022 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
OAOzan Akıncı
Ozan Akıncı
FKFadime Kutluk
Fadime Kutluk
SCSelçuk Cin
Selçuk Cin
SESüphan Ertürk
Süphan Ertürk
SYSerdar Yüceyar
Serdar Yüceyar
APAsiye Perek
Asiye Perek
Heterotopic ossification (HO) is a bone formation in a tissue other than the skeletal system. It is more often seen as a complication of orthopedic surgery; however, it is a pathological condition that might be observed during the healing process of abdominal incisions in the midline. The aim of this study is to present a case of a 63-year-old male patient with the complaints of induration and pain on the region of his previous incision through which he had been operated for achalasia. HO is also discussed in the light of the current literature.


31 May 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
SCSelçuk Cin
Selçuk Cin
HAHilal Aki
Hilal Aki
TETUGRUL ELVERDI
TUGRUL ELVERDI
DÖDeniz Özmen
Deniz Özmen
ASAyse Salihoglu
Ayse Salihoglu
The aim of this study is to investigate whether there is a cut-off value for PD-L1 expression in large B-cell lymphomas that predicts prognosis, and to clarify the relationship between PD-L1 expression and histopathological as well as clinical parameters. The study included a total of 130 patients who were diagnosed with large B-cell lymphoma at Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Pathology Department. Biopsy samples were assessed using the PD-L1 immunohistochemical antibody (Dako, 22C3 clone). The patients had a mean age of 54 ± 17 years, with a median age of 56 years. No statistically significant difference was observed between the groups in terms of survival when the 30% cut-off value was used. However, a noteworthy discrepancy in survival became apparent when the cut-off point was established at 70%. Among the diffuse large B-cell lymphoma-not otherwise specified (DLBCL-NOS) category, the activated B-cell-like (ABC-like) phenotype showed higher PD-L1 expression compared to the germinal center B-cell-like (GCB-like) phenotype. Immunohistochemical PD-L1 expression emerged as a prognostic factor, particularly significant in the ABC-like phenotype.